Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ra Medical Systems Inc (RMED)

Ra Medical Systems Inc (RMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ra Medical Systems Inc 2070 Las Palmas Drive Carlsbad CA 92011 USA

P: 760-804-1648

Description:

Ra Medical Systems, Inc. is a commercial-stage medical device company. It develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company's product pipeline consists of DABRA which is a minimally-invasive excimer laser and disposable catheter system used by physicians as a tool in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease, a form of peripheral artery disease, or above- and below-the-knee. Pharos Excimer Laser is a powerful 308 nm ultraviolet-B excimer laser used by physicians as a tool to treat chronic skin diseases, including psoriasis, vitiligo, atopic dermatitis and leukoderma. Ra Medical Systems, Inc. is based in Carlsbad, California.

Key Statistics

Overview:

Market Capitalization, $K 9,141
Shares Outstanding, K 32,300
Annual Sales, $ 20 K
Annual Net Income, $ -25,070 K
Last Quarter Sales, $ 10 K
Last Quarter Net Income, $ -8,290 K
60-Month Beta 1.57
% of Insider Shareholders 12.30%
% of Institutional Shareholders 2.82%
Float, K 28,327
% Float 87.70%

Growth:

1-Year Return -90.43%
3-Year Return -99.68%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.27 on 05/16/22
Next Earnings Date N/A
Earnings Per Share ttm -6.63
EPS Growth vs. Prev Qtr 78.05%
EPS Growth vs. Prev Year 89.11%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 11/17/20

RMED Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -152.46%
Return-on-Assets % -112.57%
Profit Margin % -125,350.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 405.95
Price/Cash Flow N/A
Price/Book 0.49
Book Value/Share 1.95
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar